Keywords: taxotere, gets, priority, japan, review, mhrpc, french

Taxotere gets priority Japan review for mHRPC

Article | 18 June 2007

Print This

French drug major Sanofi-Aventis' cancer drug Taxotere (docetaxel) is under priority review by Japan's Ministry of Health, Labor and Welfare ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in